Login Register Cart 0
Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

High Frequency of the Opioid Receptor µ-1 (OPRM1) A118G Polymorphism, an Opioid Drug Therapy Related Gene, in the Indonesian Population

Author(s): Alvina Arum Puspitasari, Zullies Ikawati*, Sri Swasthikawati and Anindya Rahmawati

Volume 17, Issue 1, 2020

Page: [64 - 69] Pages: 6

DOI: 10.2174/1875692117666191211154755

open access plus

Abstract

Background: The opioid receptor μ-1 (OPRM1) has become one of the most studied genes in pharmacogenetics, as this gene encodes the μ-opioid receptor (MOR), which plays a role in opioid drugs response, as well as in various disorders. One of its variants, A118G, which is found at a high frequency in the Asian population, has been associated with loss of sensitivity to and an increased requirement for analgesics in the treatment of pain, increased pain sensitivity, various types of substance dependencies, and the development of breast cancer. However, there are still limited reports about this gene polymorphism in the Indonesian population.

Objective: The study aimed to determine the allele frequencies of the OPRM1 A118G polymorphism among the Indonesian population.

Method: A cross-sectional study of 158 subjects, comprising 79 males and 79 females, was conducted among Indonesians, and genotype analysis was carried out by a modified allele-specific Polymerase Chain Reaction (PCR) method.

Results: A frequency of 60.4% was found for the G allele among Indonesian samples, with a higher frequency being present in males (66.5%). The A allele was found at frequencies of 33.5% and 45.6% in males and females, respectively. A significant difference in allele frequency was found between males and females (p = 0.029, OR = 1.659, 95% CI [1.052–2.614]), while there was no significant difference in genotype frequencies between groups.

Conclusion: A high prevalence of the OPRM1 A118G polymorphism was found in the Indonesian population, with the G allele frequency tending to be higher in males.

Keywords: OPRM1, A118G, opioid receptor, gender, gene polymorphism, allele-specific PCR.

« Previous
Graphical Abstract

[1]
Schwantes-An TH, Zhang J, Chen LS, et al. Association of the OPRM1 variant rs1799971 (A118G) with non-specific liability to substance dependence in a collaborative de novo meta-analysis of European-ancestry cohorts. Behav Genet 2016; 46(2): 151-69.
[http://dx.doi.org/10.1007/s10519-015-9737-3] [PMID: 26392368]
[2]
Valentino RJ, Volkow ND. Untangling the complexity of opioid receptor function. Neuropsychopharmacology 2018; 43(13): 2514-20.
[http://dx.doi.org/10.1038/s41386-018-0225-3] [PMID: 30250308]
[3]
Dlugos AM, Hamidovic A, Hodgkinson C, et al. OPRM1 gene variants modulate amphetamine-induced euphoria in humans. Genes Brain Behav 2011; 10(2): 199-209.
[http://dx.doi.org/10.1111/j.1601-183X.2010.00655.x] [PMID: 21029375]
[4]
Hart A, de Wit H, Palmer A. Genetic factors modulating the response to stimulant drugs in humans. Curr Top Behav Neurosci 2012; 12: 537-77.
[5]
Zahari Z, Ismail R. Impact of opioid receptor, Mu 1 (OPRM1) polymorphisms on pain sensitivity and clinical response to opioid analgesic therapy. Curr Pharmacogenomics Person Med 2013; 11: 59-75.
[http://dx.doi.org/10.2174/1875692111311010009]
[6]
Sun J, Chen SR, Chen H, Pan HL. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia. J Physiol 2019; 597(6): 1661-75.
[http://dx.doi.org/10.1113/JP277428] [PMID: 30578671]
[7]
Crist RC, Reiner BC, Berrettini WH. A review of opioid addiction genetics. Curr Opin Psychol 2019; 27: 31-5.
[http://dx.doi.org/10.1016/j.copsyc.2018.07.014] [PMID: 30118972]
[8]
Kumar P, Pokotylyuk I, Kulshrestha S, Loewy Z. Clinical relevance of µ-Opioid receptor A118G polymorphism in demographically variant populations. EC Pharmacol Toxicol 2018; 6: 228-36.
[9]
Hwang IC, Park JY, Myung SK, Ahn HY, Fukuda K, Liao Q. OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis. Anesthesiology 2014; 121(4): 825-34.
[http://dx.doi.org/10.1097/ALN.0000000000000405] [PMID: 25102313]
[10]
Ahmed M, Ul Haq I, Faisal M, Waseem D, Taqi MM. Implication of OPRM1 A118G polymorphism in opioids addicts in Pakistan: In vitro and in silico analysis. J Mol Neurosci 2018; 65(4): 472-9.
[http://dx.doi.org/10.1007/s12031-018-1123-1] [PMID: 30033503]
[11]
Zahari Z, Siong L, Yeh L, et al. 118A>G And IVS2+691G>C polymorphisms of OPRM1 gene have no influence on cold-pain sensitivity among healthy opioid-naive malay males. Int J Pharm Pharm Sci 2016; 8: 73-80.
[12]
Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 2009; 169(4): 505-14.
[http://dx.doi.org/10.1093/aje/kwn359] [PMID: 19126586]
[13]
Diatchenko L, Robinson JE, Maixner W. Elucidation of mu-Opioid gene structure: How genetics can help predict responses to opioids. Eur J Pain Suppl 2011; 5(2): 433-8.
[http://dx.doi.org/10.1016/j.eujps.2011.08.022] [PMID: 22102848]
[14]
Green MR, Sambrook J. Nested polymerase chain reaction (PCR). Cold Spring Harb Protoc 2019; 2019(2)
[http://dx.doi.org/10.1101/pdb.prot095182] [PMID: 30710024]
[15]
Fukuda K, Hayashida M, Ikeda K, Koukita Y, Ichinohe T, Kaneko Y. Diversity of opioid requirements for postoperative pain control following oral surgery--is it affected by polymorphism of the μ-opioid receptor? Anesth Prog 2010; 57(4): 145-9.
[http://dx.doi.org/10.2344/0003-3006-57.4.145] [PMID: 21174568]
[16]
Zahari Z, Ibrahim MA, Musa N, Tan SC, Mohamad N, Ismail R. Sleep quality and OPRM1 polymorphisms: A cross-sectional study among opioid-naive individuals Braz J Pharm Sci 2018. 54e17217
[http://dx.doi.org/10.1590/s2175-97902018000117217]
[17]
Kumar D, Chakraborty J, Das S. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36(2): 225-30.
[http://dx.doi.org/10.1016/j.pnpbp.2011.10.018] [PMID: 22138325]
[18]
Hofer T, Ray N, Wegmann D, Excoffier L. Large allele frequency differences between human continental groups are more likely to have occurred by drift during range expansions than by selection. Ann Hum Genet 2009; 73(1): 95-108.
[http://dx.doi.org/10.1111/j.1469-1809.2008.00489.x] [PMID: 19040659]
[19]
Mattei J, Parnell LD, Lai CQ, et al. Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites. BMC Genet 2009; 10: 45.
[http://dx.doi.org/10.1186/1471-2156-10-45] [PMID: 19682384]
[20]
Ding S, Chen B, Zheng Y, Lu Q, Liu L, Zhuge QC. Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. BMC Psychiatry 2013; 13(107): 107.
[http://dx.doi.org/10.1186/1471-244X-13-107] [PMID: 23560613]
[21]
Bunten H, Liang WJ, Pounder DJ, Seneviratne C, Osselton D. Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations. J Anal Toxicol 2011; 35(7): 431-7.
[http://dx.doi.org/10.1093/anatox/35.7.431] [PMID: 21871151]
[22]
Cieślińska A, Sienkiewicz-Szłapka E, Kostyra E, et al. μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer. Tumour Biol 2015; 36(6): 4655-60.
[http://dx.doi.org/10.1007/s13277-015-3113-z] [PMID: 25618602]
[23]
Yu Z, Wen L, Shen X, Zhang H. Effects of the OPRM1 A118G polymorphism (rs1799971) on opioid analgesia in cancer pain: A systematic review and meta-analysis. Clin J Pain 2019; 35(1): 77-86.
[http://dx.doi.org/10.1097/AJP.0000000000000636] [PMID: 30028366]
[24]
Vieira CMP, Fragoso RM, Pereira D, Medeiros R. Pain polymorphisms and opioids: An evidence based review. Mol Med Rep 2019; 19(3): 1423-34.
[PMID: 30592275]
[25]
Wang SC, Tsou HH, Ho IK, Lin KM, Liu YL. Pharmacogenomics study in a Taiwan methadone maintenance cohort. Yao Wu Shi Pin Fen Xi 2013; 21(4): S62-8.
[http://dx.doi.org/10.1016/j.jfda.2013.09.036] [PMID: 25278738]

Rights & Permissions Print Cite
Article Metrics
9
© 2024 Bentham Science Publishers | Privacy Policy